11-Deoxy-inter-oxa-19-oxo-PGF1 compounds

ABSTRACT

The present invention provides novel 11-deoxy-inter-oxa-19-oxo-PGF 1  compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.

CROSS REFERENCE TO RELATED APPLICATION

This application is a division of Ser. No. 025,879, filed Apr. 2, 1979,now pending.

DESCRIPTION Background of the Invention

The present invention relates to novel prostaglandin analogs.Particularly, the invention relates to prostaglandin analogs wherein theC-19 position is substituted by oxo, i.e., 19-keto-PG compounds or19-oxo-PG compounds. Most particularly, the present invention relates tonovel 11-deoxy-inter-oxa-19-oxo-PGF₁ compounds, a disclosure of thepreparation and pharmacological use of which is incorporated here byreference from U.S. Ser. No. 025,899, filed Apr. 2, 1979, issued as U.S.Pat. No. 4,228,104 on Oct. 14, 1980.

PRIOR ART

Prostaglandins exhibiting a variety of substitution at the C-19 positionare known. See particularly J. C. Sih, et al., JACS 91:3685 (1969)wherein 19-oxo-PGE₂ and 13,14-dihydro-19-oxo-PGE₁ are disclosed.Further, Chemical Abstracts 86:43265H purportedly discloses 19-oxo-PGF₂α. The abstract is derived from Japanese Kokai No. 76 82,245.

SUMMARY OF THE INVENTION

The present invention particularly provides:

a compound of the formula ##STR1## wherein D is (1) (CH₂)₃ --O--CH₂ --,

(2) (CH₂)₃ --O--CF₂ --, or

(3) --CH₂ --O--(CH₂)₃ --;

wherein Q is α-OH:β-R₅ or α-R₅ :β-OH, wherein R₅ is hydrogen or methyl;

wherein R₆ is

(a) hydrogen,

(b) alkyl of one to 12 carbon atoms, inclusive,

(c) cycloalkyl of 3 to 10 carbon atoms, inclusive,

(d) aralkyl of 7 to 12 carbon atoms, inclusive,

(e) phenyl,

(f) phenyl substituted with one, 2, or 3 chloro or alkyl groups of oneto 3 carbon atoms, inclusive,

(g) --(p--Ph)--CO--CH₃,

(h ) 13 (p-Ph)--NH--CO--(p-Ph)--NH--CO--CH₃,

(i) --(p-Ph)--NH--CO--(p-Ph),

(j) --(p-Ph)--NH--CO--CH₃,

(k) --(p-Ph)--NH--CO--NH₂,

(l) --(p-Ph)--(CH═N--NH--CO--NH₂,

(m) β-naphthyl,

(n) --CH₂ --CO--R₂₈,

wherein (p-Ph) is para-phenyl or inter-para-phenylene,

wherein R₂₈ is phenyl, p-bromophenyl, p-biphenylyl, p-nitrophenyl,p-benzamidophenyl, or 2-naphthyl, or

(o) a pharmacologically acceptable cation;

wherein R₃ and R₄ are hydrogen, methyl, or fluoro, being the same ordifferent, with the proviso that one of R₃ and R₄ is fluoro only whenthe other is hydrogen or fluoro; and

wherein X is cis- or trans-CH═CH--.

The compounds of the present invention are particularly useful forinducing prostaglandin-like biological effects, as described in UnitedStates Serial No. 026,066. Uses of compounds in accordance with thepresent invention include, therefore, antiasthmatic indications.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention particularly relates to:

11-deoxy-5-oxa-19-oxo-PGF₁ α, and

11-deoxy-5-oxa-(15R)-19-oxo-PGF₁ α.

I claim:
 1. A compound of the formula ##STR2## wherein D is (1) (CH₂)₃--O--CH₂ --,(2) (CH₂)₃ --O--CF₂ --, or (3) --CH₂ --O--(CH₂)₃ --; whereinQ is α-OH:β-R₅ or α-R₅ :β-OH, wherein R₅ is hydrogen or methyl; whereinR₆ is(a) hydrogen, (b) alkyl of one to 12 carbon atoms, inclusive, (c)cycloalkyl of 3 to 10 carbon atoms, inclusive, (d) aralkyl of 7 to 12carbon atoms, inclusive, (e) phenyl, (f) phenyl substituted with one, 2,or 3 chloro or alkyl groups of one to 3 carbon atoms, inclusive, (g)--(p-Ph)--CO--CH₃, (h) --(p-Ph)--NH--CO--(p-Ph)--NH--CO--CH₃, (i)--(p-Ph)--NH--CO--(p-Ph), (j) --(p-Ph)--NH--CO--CH₃, (k)--(p-Ph)--NH--CO--NH₂, (l) --(p-Ph)--CH═N--NH--CO--NH₂, (m) β-naphthyl,(n) --CH₂ --CO--R₂₈, wherein (p-Ph) is para-phenyl orinter-para-phenylene, wherein R₂₈ is phenyl, p-bromophenyl,p-biphenylyl, p-nitrophenyl, p-benzamidophenyl, or 2-naphthyl, or(o) apharmacologically acceptable cation; wherein R₃ and R₄ are hydrogen,methyl, or fluoro, being the same or different, with the proviso thatone of R₃ and R₄ is fluoro only when the other is hydrogen or fluoro;and wherein X is cis- or trans-CH═CH--.
 2. A compound according to claim1, wherein R₆ is hydrogen or methyl.
 3. 11-Deoxy-5-oxa-19-oxo-PGF₁ α, acompound according to claim
 2. 4. 11-Deoxy-5-Oxa-15(R)-19-oxo-PGF₁ α, acompound according to claim 2.